Serial #88879529
LIVE

Serial Number

88879529

Owner

AVECTAS LIMITED

Attorney

Susan Neuberger Weller

Filing Date

Apr 20, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #88879529 Trademark

Serial Number: 88879529 • Registration: 6610592

Serial #88879529 is a trademark filed by AVECTAS LIMITED on April 20, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

AVECTAS LIMITED (6 trademarks)

34 FITZWILLIAM SQUARE
SOUTH DUBLIN 2 , IE

Entity Type: 99

Trademark Details

Filing Date

April 20, 2020

Registration Date

January 11, 2022

Published for Opposition

October 26, 2021

Goods & Services

Scientific apparatus and instruments, namely, scientific apparatus and instruments for the transfer of biological molecules into living cells, namely, a transfection system comprised of a preinstalled software controller for operating the transfection system, transfection chamber, tubes, filters, connectors, bags, and reagents; replacement parts and fittings for the aforesaid goods

Pharmaceutical preparations for the treatment of immune-oncological disorders, cancer, diabetes, respiratory, heart, neurological and auto immune disorders; stem cells for medical purposes; living cells for medical use

Stem cells for research purposes

Surgical apparatus and instruments; medical apparatus and instruments for delivery of macro molecules to the mouth, nose, airway, lungs, namely, leukapheresis, plasmapheresis and extracorporeal photopheresis machines; replacement parts and fittings for the aforesaid goods

Scientific and technological services, namely, research and engineering process design services in the field of pharmaceuticals, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical and scientific research; pharmaceutical research and development; and clinical testing, namely, conducting clinical trials for others in the field of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of probes, reagents and bioassays for industrial, clinical, and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid

Filing History

REGISTERED-PRINCIPAL REGISTER
Jan 11, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 26, 2021 NPUB
PUBLISHED FOR OPPOSITION
Oct 26, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 6, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 18, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 17, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 17, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 17, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 17, 2021 CNEA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 20, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 20, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 20, 2021 REAP
NOTIFICATION OF FINAL REFUSAL EMAILED
May 7, 2021 GNFN
FINAL REFUSAL E-MAILED
May 7, 2021 GNFR
FINAL REFUSAL WRITTEN
May 7, 2021 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 21, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 21, 2021 CRFA
ASSIGNED TO LIE
Apr 14, 2021 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 8, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRN
NON-FINAL ACTION E-MAILED
Jul 14, 2020 GNRT
NON-FINAL ACTION WRITTEN
Jul 14, 2020 CNRT
ASSIGNED TO EXAMINER
Jul 13, 2020 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Apr 30, 2020 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 29, 2020 NWOS
NEW APPLICATION ENTERED
Apr 23, 2020 NWAP